Safety, Efficacy and Pharmacokinetics of Rifaximin in Patients With Moderate-to-severe Papulopustular Rosacea

PHASE2CompletedINTERVENTIONAL
Enrollment

216

Participants

Timeline

Start Date

October 5, 2021

Primary Completion Date

October 20, 2022

Study Completion Date

October 20, 2022

Conditions
Papulopustular Rosacea
Interventions
DRUG

Rifaximin

Rifaximin tablets

DRUG

Placebo

Placebo tablets

Trial Locations (38)

10022

JUVA Skin and Laser Center, New York

19103

Paddington Testing Co, Inc, Philadelphia

23233

West End Dermatology Associates, Richmond

27262

Dermatology Consulting Services, PLLC, High Point

28277

Onsite Clinical Solutions, Charlotte

30060

DelRicht Research, Marietta

32174

Leavitt Medical Associates of Florida, Ormond Beach

33014

Savin Medical Group, Miami Lakes

33016

Sweet Hope Research Specialty, Inc., Hialeah

33486

Skin Care Research, Boca Raton

33511

MOORE Clinical Research,Inc., Brandon

40241

DS Research, Louisville

47129

DS Research, Clarksville

48084

Revival Research Institute, LLC., Troy

48192

Grekin Skin Care Institute, Wyandotte

65406

MediSearch Clinical Trials, Saint Joseph

70115

DelRicht Research, New Orleans

70360

DelRicht Research Houma Louisiana, Houma

70433

Delricht Research Covington LA, Covington

70809

Delricht Research Baton Rouge LA, Baton Rouge

72916

Johnson Dermatology, Fort Smith

74114

DelRicht Research, Tulsa

75034

DelRicht Research Frisco Texas, Frisco

75230

Dermatology Treatment and Research Center, Dallas

78213

Progressive Clinical Research, San Antonio

78660

Austin Institute for Clinical Research, Pflugerville

79925

3A Research, El Paso

84117

Velocity Clinical Research, Salt Lake City

85365

Dermatology Research Ventures, Yuma

89148

JDR Dermatology Research, Las Vegas

90017

Metropolis Dermatology, Los Angeles

90057

LA Universal Research Center, Los Angeles

90806

Long Beach Clinical Trials, Long Beach

92121

Cosmetic Laser Dermatology, San Diego

92122

UCSD, San Diego

92123

University Clinical Trials, Inc., San Diego

97210

Oregon Dermatology and Research Center, Portland

401217

Skin Science PLLC, Louisville

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

bioRASI, LLC

INDUSTRY

lead

Alfasigma S.p.A.

INDUSTRY